Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-24 · accession 0001209191-23-004945 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-25 | 2023-01-24 | VIR | Pang Phillip | Chief Medical Off | A - Grant | $2.13 | +30.0K | 174.0K | +21% | +$63.9K |
| D | 2023-01-25 | 2023-01-24 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $30.00 | -30.0K | 144.0K | -17% | -$900.0K |
| DM | 2023-01-25 | 2023-01-24 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $0.00 | -30.0K | 37.5K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-24 | A | A | 25,406 | $1.58 | 169,406 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-24 | S | D | 30,000 | $30.00 | 144,000 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Common | Common Stock | 2023-01-24 | A | A | 4,594 | $5.18 | 174,000 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-01-24 | M | D | 25,406 | $0.00 | 13,576 | D | $1.58 · — to 2028-07-19 | 25,406 Common Stock | (F3) 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-01-24 | M | D | 4,594 | $0.00 | 37,535 | D | $5.18 · — to 2029-03-11 | 4,594 Common Stock | (F4) 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares vest in 36 equal monthly installments thereafter. |